- Residency - UT Southwestern Medical Center (2013-2015), Internal Medicine
- Internship - UT Southwestern Medical Center (2012-2013), Internal Medicine
- Medical School - Wake Forest University School of Medicine (2008-2012)
- Fellowship - UT Southwestern Medical Center (2016-2019), Gastroenterology
Ariel Aday, M.D.
Program Director for the Gastroenterology Fellowship Program
- Internal Medicine - Digestive and Liver Diseases
- Gastroenterology
- Esophageal Motility Disorders
Biography
Ariel Aday, M.D., is an Assistant Professor in the Department of Internal Medicine at UT Southwestern Medical Center and a member of the Division of Digestive & Liver Diseases. She serves as the Program Director of the Gastroenterology Fellowship Program. She brings enthusiasm for medical education and clinical research.
Originally from Bristol, Virginia, Dr. Aday earned her medical degree at Wake Forest University School of Medicine in Winston-Salem, North Carolina. She completed her residency in internal medicine at UT Southwestern where she also served as Chief Resident. She remained at UT Southwestern to complete her gastroenterology fellowship.
Board certified in internal medicine and gastroenterology, Dr. Aday initially joined the UT Southwestern faculty in 2015 as an Assistant Instructor during her tenure as Chief Medicine Resident. She rejoined the faculty in 2019 and quickly resumed her involvement as a GME leader.
Dr. Aday is an active member in numerous professional societies, including the American College of Gastroenterology Training Committee, the American Gastroenterological Association Academy of Educators, and the Association of Specialty Professors Fellowship Education Committee through the Alliance for Academic Internal Medicine. She serves as Chair of the Resident Resources Subcommittee through the American College of Gastroenterology and is actively involved on the Abstract Review Committees for both Digestive Diseases Week and the ACG annual meeting. Dr. Aday spearheaded development of a society-agnostic Gastroenterology Program Director Workgroup to improve gastroenterology fellowship training programs supported by the ACGME Gastroenterology Review Committee Members.
In 2024, Dr. Aday was selected for the Rising Star Award by the Graduate Medical Education office for her significant contributions as a gastroenterology fellowship program director and other GME efforts.
Personal Note
Outside of medicine, Dr. Aday enjoys being a mother to her son and daughter, traveling, and reformer Pilates.
Education & Training
Professional Associations & Affiliations
- Dallas County Medical Society (2015), Member
- Texas Medical Association (2015), Member
- Texas Society for Gastroenterology & Endoscopy (2022), Member
- American Neurogastroenterology and Motility Society (2021)
- American College of Gastroenterology (2019), Member
- American Gastroenterology Association (2016), Member
- American Association for the Study of Liver Diseases (2016-2021), Member
- Alliance for Academic Internal Medicine (2015)
Honors & Awards
- Advanced Practice Provider Physician Partner of the Year 2024, Parkland Health
- Rising Star Award 2024, UT Southwestern GME
- Leadership Emerging in Academic Departments (LEAD) Scholar 2023, UT Southwestern
- Clinical Early Career Investigator Travel Award 2018, American Association for the Study of Liver Diseases (AASLD)
- AASLD Liver Cup 2017, National Debate Winner
- Global Health Initiative 2015, First UT Southwestern representative at Universidad Peruana Cayetano Heredia in Lima, Peru
- Residency Council 2012-2015, Representative, peer-selected committee
- Ann Eller Pardue Endowed Scholarship 2008-2010
Books & Publications
-
Publications
-
Ketamine-Induced Sclerosing Cholangitis (KISC) in a Critically Ill Patient With COVID-19
Knooihuizen SA, Aday A, Lee WM Hepatology 2021 Jul 74 519-521 -
Letter to the Editor: Response to Letter Concerning Our Pregnancy Manuscript
Casey L, Aday A, Rule J, Lee WM Hepatology 2021 Jan 73 465 -
Acute Liver Failure (ALF) in Pregnancy: How Much Is Pregnancy Related?
Author Collaboration ft, Casey LC, Fontana RJ, Aday A, Nelson DB, Rule JA, Gottfried M, Tran M, Lee WM Hepatology 2020 Oct 72 1366-1377 -
Acute on Chronic Liver Failure: Definition and Implications
Aday A, O'Leary JG Clinics in Liver Disease 2020 Aug 24 521-534 -
Donor-Specific Antibodies’ Meaningful Impact on Liver Transplantation
Aday AW, O’Leary JG Liver Transplantation 2018 Aug 24 999-1000 -
CON (“The window is closed”): In patients with cirrhosis with ascites, the clinical risks of nonselective beta-blocker outweigh the benefits and should NOT be prescribed
Aday AW, Rich NE, Mufti AR, Tujios SR Clinical Liver Disease 2018 May 11 123-127 -
Food for thought: Importance of nutrition in alcoholic hepatitis
Aday AW, Mitchell MC Practical Gastroenterology 2018 Mar 42 30-36 -
Alcoholic hepatitis: Current trends in management
Aday AW, Mitchell MC, Casey LC Current Opinion in Gastroenterology 2017 May 33 142-148 -
The beneficial effect of beta-blockers in patients with cirrhosis, portal hypertension and ascites
Aday AW, Mayo MJ, Elliott A, Rockey DC American Journal of the Medical Sciences 2016 351 169-176 -
An Unusual Rash in a Middle-Aged Man
Pandey A, Aday A Journal of general internal medicine 2014 Dec 29 1711-1712 -
Erratum: An essential role for the association of CD47 to SHPS-1 in skeletal remodeling(Journal of Bone and Mineral Research ((2011) 26: 11 (2792))
Maile LA, Demambro VE, Wai C, Aday AW, Capps BE, Beamer WG, Rosen CJ, Clemmons DR Journal of Bone and Mineral Research 2011 Nov 26 2792 -
An essential role for the association of CD47 to SHPS-1 in skeletal remodeling
Maile LA, Demambro VE, Wai C, Aday AW, Capps BE, Beamer WG, Rosen CJ, Clemmons DR Journal of Bone and Mineral Research 2011 Sep 26 2068-2081 -
Modulation of integrin antagonist signaling by ligand binding of the heparin-binding domain of vitronectin to the αVβ3 integrin
Maile LA, Aday AW, Busby WH, Sanghani R, Veluvolu U, Clemmons DR Journal of Cellular Biochemistry 2008 Oct 105 437-446 -
Integrin-associated protein association with src homology 2 domain containing tyrosine phosphatase substrate 1 regulates IGF-i signaling in vivo
Maile LA, Capps BE, Miller EC, Aday AW, Clemmons DR Diabetes 2008 Oct 57 2637-2643 -
Glucose regulation of integrin-associated protein cleavage controls the response of vascular smooth muscle cells to insulin-like growth factor-I
Maile LA, Capps BE, Miller EC, Allen LB, Veluvolu U, Aday AW, Clemmons DR Molecular Endocrinology 2008 May 22 1226-1237
-
Ketamine-Induced Sclerosing Cholangitis (KISC) in a Critically Ill Patient With COVID-19
Research
- Medical Education
Clinical Focus
- Gastroenterology
- Esophageal Motility Disorders
- Disorders of Gut-Brain Interaction
- Diverticular Diseases